Anita Dushyanth
Stock Analyst at Berenberg
(2.78)
# 1,895
Out of 4,711 analysts
4
Total ratings
75%
Success rate
15.74%
Average return
Main Sectors:
Stocks Rated by Anita Dushyanth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| URGN UroGen Pharma | Initiates: Buy | $20 | $10.64 | +87.97% | 1 | Apr 27, 2022 | |
| SERA Sera Prognostics | Initiates: Buy | $13 | $8.78 | +48.06% | 1 | Apr 27, 2022 | |
| BTAI BioXcel Therapeutics | Initiates: Buy | $75 | $0.34 | +21,894.13% | 1 | Apr 9, 2021 | |
| PCRX Pacira BioSciences | Initiates: Buy | $93 | $18.98 | +389.99% | 1 | Apr 9, 2021 |
UroGen Pharma
Apr 27, 2022
Initiates: Buy
Price Target: $20
Current: $10.64
Upside: +87.97%
Sera Prognostics
Apr 27, 2022
Initiates: Buy
Price Target: $13
Current: $8.78
Upside: +48.06%
BioXcel Therapeutics
Apr 9, 2021
Initiates: Buy
Price Target: $75
Current: $0.34
Upside: +21,894.13%
Pacira BioSciences
Apr 9, 2021
Initiates: Buy
Price Target: $93
Current: $18.98
Upside: +389.99%